Author Question: The nurse checks the coagulation studies on a client who is not receiving any type of anticoagulant ... (Read 64 times)

mmm

  • Hero Member
  • *****
  • Posts: 558
The nurse checks the coagulation studies on a client who is not receiving any type of anticoagulant therapy. Which finding should be reported to the physician?
 
  1. Platelet count is 250,000 mm3.
  2. APTT is 25 seconds.
  3. INR is 2.5.
  4. Prothrombin time is 20 seconds.

Question 2

A client is having a D-dimer test completed. What preparation should the nurse provide for this client before the test? (Select all that apply.)
 
  1. Monitor vital signs.
  2. Keep on strict bedrest.
  3. Report unexplained bleeding.
  4. Position in the prone position.
  5. Keep on nothing by mouth status.



helenmarkerine

  • Sr. Member
  • ****
  • Posts: 324
Answer to Question 1

Answer: 4

1. Platelets are 150,000-450,000 mm3.
2. A normal APTT is 25-35 seconds.
3. A normal INR is 2.0-3.0.
4. A prothrombin time of 20 seconds is prolonged.

Answer to Question 2

Answer: 1, 3

1. Vital signs should be monitored for this test.
2. Strict bedrest is not required for the D-dimer test.
3. The nurse should report manifestations such as unexplained bleeding.
4. The prone position is not required for this test.
5. No food or fluid restriction is required for the D-dimer test.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Did you know?

Signs of depression include feeling sad most of the time for 2 weeks or longer; loss of interest in things normally enjoyed; lack of energy; sleep and appetite disturbances; weight changes; feelings of hopelessness, helplessness, or worthlessness; an inability to make decisions; and thoughts of death and suicide.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

Did you know?

People about to have surgery must tell their health care providers about all supplements they take.

For a complete list of videos, visit our video library